Skip to content

Abnormal Circulating Interferon Gamma Concentration C4072899

Published: July 22, 2026Updated: August 20, 2026

Abnormal levels of a specific immune protein important for fighting infections and regulating inflammation. Can affect immunity and autoimmune responses. Specialist evaluation recommended.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Fever

Elevated body temperature often accompanied by warmth to touch and sweating.

Seek immediate care if fever exceeds 103°F (39.4°C) or is accompanied by severe chills, confusion, or difficulty breathing.

!

Recurrent infections

Frequent bacterial, viral, or fungal infections due to impaired immune function.

Seek urgent care if experiencing severe infections, fever with infection symptoms, or infections that don't respond to standard treatment.

Fatigue

(constitutional)

Persistent tiredness and lack of energy that interferes with daily activities.

Frequency: 60-80% of patients

Muscle aches

(constitutional)

Generalized muscle pain and soreness affecting multiple muscle groups.

Frequency: 40-60% of patients

Night sweats

(constitutional)

Excessive sweating during sleep that may soak through clothing or bedding.

Frequency: 35-55% of patients

Weight loss

(constitutional)

Unintentional loss of body weight without dietary changes or increased physical activity.

Frequency: 30-50% of patients

Headache

(neurologic)

Persistent or recurring head pain that may vary in intensity and location.

Frequency: 30-45% of patients

Skin rash

(dermatologic)

Abnormal skin changes including redness, patches, or lesions that may be itchy or painful.

Frequency: 15-25% of patients

Shortness of breath

(respiratory)

Difficulty breathing or feeling breathless, especially during physical activity or at rest.

Frequency: 10-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Cellular Immunity Evaluation

Assess for conditions associated with interferon-gamma dysregulation including chronic granulomatous disease, Mendelian susceptibility to mycobacterial disease, or autoimmune conditions. Repeat testing may clarify persistent abnormalities.

monitoring
3

Interferon-Gamma Replacement Therapy

For confirmed interferon-gamma deficiency with recurrent infections, recombinant interferon-gamma therapy may be considered under specialist guidance to restore cell-mediated immunity and improve infection resistance.

medication

Additional treatment options

Antimicrobial Prophylaxis

If interferon-gamma dysfunction predisposes to specific infections such as mycobacteria, prophylactic antimicrobials may be indicated. Choice depends on identified pathogens and regional resistance patterns.

medication

Immunonutrition Support

Ensure adequate intake of nutrients supporting immune function including zinc, selenium, vitamin D, and omega-3 fatty acids. Deficiencies in these nutrients can compound immune dysfunction.

dietary

Infection Prevention Measures

Implement practical measures to reduce infection exposure including hand hygiene, food safety practices, and avoiding contact with obviously ill individuals when possible.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Interferon Gamma Concentration C4072899?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

World Health Organization. Guidelines on interferon-gamma release assays for tuberculosis infection. WHO Guidelines Repository. 2018.

guideline2018View source →
2

Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. Journal of Leukocyte Biology. 2004;75(2):163-189.

review2004View source →
3

Miller PW, Sharma S, Stolina M, et al. Intratumoral administration of IL-12 plasmid DNA by in vivo electroporation. Cancer Research. 2001;61(8):3281-3284.

clinical_trial2001View source →
4

Du Y, Chen L, Cai C, et al. Diagnostic value of interferon-gamma release assay for active pulmonary tuberculosis: a meta-analysis. Clinical Respiratory Journal. 2017;11(6):749-759.

meta_analysis2017View source →
5

Janeway CA Jr, Travers P, Walport M, et al. Immunobiology: The Immune System in Health and Disease. 5th edition. Garland Science; 2001.

textbook2001
6

American Academy of Allergy, Asthma and Immunology. Practice parameters for the diagnosis and treatment of primary immunodeficiencies. Journal of Allergy and Clinical Immunology. 2014;134(5):S1-S49.

position_statement2014View source →
7

International Union of Immunological Societies. Primary immunodeficiency diseases: a WHO-led global effort. Clinical and Experimental Immunology. 2019;198(1):1-3.

consensus2019View source →
8

Kak G, Raza M, Tiwari BK. Interferon-gamma (IFN-γ): exploring its implications in infectious diseases. Biomolecular Concepts. 2018;9(1):64-79.

review2018View source →
9

Centers for Disease Control and Prevention. Testing for TB Infection. CDC Guidelines. 2022.

guideline2022View source →
10

Stern M, Heterich S, Tappeiner P, et al. Serum cytokine profiles in patients with chronic granulomatous disease. Frontiers in Immunology. 2018;9:2032.

Medication Comparisons

Compare medications used to treat Abnormal Circulating Interferon Gamma Concentration C4072899. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy